-
Mashup Score: 0Simultaneous Hybrid Coronary Revascularization vs Conventional Strategies for Multivessel Coronary Artery Disease: A 10-Year Follow-Up - 1 year(s) ago
Abstract Background Although evidence is sufficient to confirm that hybrid coronary revascularization (HCR) is safe and effective in the short term, its value in the long run is debatable. Objectiv…
Categories: Expert Picks, Latest HeadlinesTweet
-
Mashup Score: 0
Abstract Background The latest iterations of devices for transcatheter aortic valve replacement (TAVR) have brought refinements to further improve patient outcomes. Objectives This study sought to …
Categories: Cardiologists, Latest HeadlinesTweet-
OPERA-TAVI registry: SE and BE devices had comparable VARC-3 device success rates, but the BE device had a higher rate of early safety. @jaccjournals https://t.co/gYkfJyG1HO https://t.co/92GJJRG86H
-
-
Mashup Score: 4Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor: The Switching Antiplatelet (SWAP)-5 Study - 1 year(s) ago
Abstract Background There are no studies specifically designed to rule out a drug-drug interaction (DDI) when cangrelor is used among patients who have been pretreated with ticagrelor. Objectives T…
Categories: Expert Picks, Latest HeadlinesTweet-
Compared to placebo, receiving #cangrelor in patients pretreated with #ticagrelor resulted in enhanced platelet inhibition, with no evidence of drug-drug interaction on pharmacokinetic and pharmacodynamic assessment. https://t.co/KiO3802oIc #JACCINT @ortega_paz @FFranchiMD https://t.co/FQhgGOaJ5S
-
-
Mashup Score: 32Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary Intervention: - 1 year(s) ago
Abstract Background Diabetes was reported to be associated with an impaired response to clopidogrel. Objectives The aim of this study was to evaluate the safety and efficacy of clopidogrel monother…
Categories: Expert Picks, Latest HeadlinesTweet-
What are the outcomes of clopidogrel after 1 month of #DAPT in pts w/ #diabetes undergoing #PCI? In this #JACCINT study, clopidogrel monotherapy after 1-month DAPT was assoc. w/ ⬇️ major bleeding w/out an ⬆️ in CV events. https://t.co/WoSgujbp9E #CardioTwitter @HirotWatanabeMD https://t.co/7STXFTe9Dw
-
-
Mashup Score: 0No Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry - 1 year(s) ago
Abstract Background Several trials demonstrated that aspirin monotherapy compared with aspirin plus clopidogrel is associated with a lower incidence of bleeding without an increased risk of ischemi…
Categories: Cardiologists, Latest HeadlinesTweet-
後輩の小張先生 @yusuke_kobari JACC Interv の論文（https://t.co/tM3Wd7PL8T）をJCOに取り上げて頂きました！重城先生、ありがとうございました！ @OCEAN_SHD 【TAVI】治療後の抗血栓薬はいらない !? [OCEAN registryより] https://t.co/gq6mP4DNkW @YouTubeより
-
-
Mashup Score: 4Timing, Selection, Modulation, and Duration of P2Y12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCI: - 1 year(s) ago
Abstract Dual antiplatelet therapy with aspirin and the oral P2Y12 inhibitor clopidogrel as the cornerstone of treatment for patients with an acute coronary syndrome (ACS) undergoing percutaneous c…
Categories: Expert Picks, Latest HeadlinesTweet-
#JACCINT SOTA review discusses the latest evidence surrounding timing, selection, modulation & duration of #P2Y12 inhibitors for #cvACS patients undergoing #PCI, w/ a focus on efficacy & safety data, practice guidelines, & residual areas of uncertainty. https://t.co/b0X3b9FTdV https://t.co/zSy3NU15mE
-
-
Mashup Score: 0Balloon-Expandable Valve for Treatment of Self-Expanding Supra-Annular Valve Failure: - 1 year(s) ago
Skip to main content Reference1. Akodad M., Sellers S., Landes U., et al. “Balloon-expandable valve for treatment of Evolut valve failure: implications on neoskirt height and leaflet overhang”. J Am Coll Cardiol Intv 2022;15:4: 368-377. View ArticleGoogle ScholarFiguresReferencesRelatedDetails …
Categories: Cardiologists, Latest HeadlinesTweet-
Proud & Congrats @J_Sathananthan @myriam_akodad @LandesUri @dmylotte @sellers_steph @johngraydonwebb et al on this S3 in Acurate-neo2 #TAVR in TAVR study showing feasible fn despite leaflet overhang. @JACCJournals #JACCINT case by @barbanti_marco et al https://t.co/OZXjTkfOPg https://t.co/9OXprZ4bqZ
-
-
Mashup Score: 2Transcatheter Aortic Valve-in-Valve Replacement for Failed Sutureless Aortic Valves: - 1 year(s) ago
Each JACC Patient Care Pathway is an immersive, multimedia case report depicting the integration of cross-specialty decision making supported by evidence-based medicine within a single patient journey.
Categories: Cardiologists, Latest HeadlinesTweet-
VIV #TAVR in Perceval suturelss SAV: beware of sizing and expansion. Just out @JACCJournals #JACCINT. Anyone has experience? https://t.co/7OMRhwnu6P @KHERA_MD @djc795 @bapat_savrtavr @TsuyoshiKaneko1 @igeorge1975 @NimeshDesaiMD @HarryDauerman @JasonFoerst @PaulMahoneyMD https://t.co/1iCSDQEv4T
-
-
Mashup Score: 3First-in-Human Dedicated Leaflet Splitting Device for Prevention of Coronary Obstruction in Transcatheter Aortic Valve Replacement: - 1 year(s) ago
Abstract Background Coronary artery obstruction is a life-threatening complication of transcatheter aortic valve replacement (TAVR) procedures. Current preventive strategies are suboptimal. Objecti…
Categories: Cardiologists, Latest HeadlinesTweet-
Just out @JACCJournals #JACCINT SHORTCUT leaflet modific FIH by @dannydvir @PPibarot @didier_tchetche @MartyBLeon @SusheelKodaliMD et al; more reproducible and adoptable? @CathElectroSurg @AdamGreenbaumMD @jamiemccabeMD @TsuyoshiKaneko1 @bapat_savrtavr https://t.co/5HuwmDU21a https://t.co/5xTIuV3gz4
-
-
Mashup Score: 3First-in-Human Dedicated Leaflet Splitting Device for Prevention of Coronary Obstruction in Transcatheter Aortic Valve Replacement: - 1 year(s) ago
Abstract Background Coronary artery obstruction is a life-threatening complication of transcatheter aortic valve replacement (TAVR) procedures. Current preventive strategies are suboptimal. Objecti…
Categories: Cardiologists, Latest HeadlinesTweet-
First-in-Human Dedicated Leaflet Splitting Device for Prevention of Coronary Obstruction in TAVR @JACCJournals A game changer? No more traditional BASILICA? https://t.co/8QoE3dOk0b https://t.co/KH5b2Dnws6
-
In a propensity score matching analysis, patients with high EuroSCORE II scores that underwent hybrid #revascularization had an associated lower #MACCE rate compared with #PCI or #CABG. https://t.co/ySnZjT8xky #JACCINT #cvCABG #revasc #cvCAD https://t.co/FnACF12poc